nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Immune system disorder—Irinotecan—colon cancer	0.003	0.003	CcSEcCtD
Meropenem—Chills—Irinotecan—colon cancer	0.00298	0.00298	CcSEcCtD
Meropenem—Pulmonary oedema—Methotrexate—colon cancer	0.00294	0.00294	CcSEcCtD
Meropenem—Hypokalaemia—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.0029	0.0029	CcSEcCtD
Meropenem—Back pain—Vincristine—colon cancer	0.00287	0.00287	CcSEcCtD
Meropenem—Sepsis—Methotrexate—colon cancer	0.00286	0.00286	CcSEcCtD
Meropenem—Flatulence—Irinotecan—colon cancer	0.00285	0.00285	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00284	0.00284	CcSEcCtD
Meropenem—Back pain—Irinotecan—colon cancer	0.0028	0.0028	CcSEcCtD
Meropenem—Abdominal distension—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Meropenem—Asthma—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Meropenem—Erythema—Fluorouracil—colon cancer	0.00277	0.00277	CcSEcCtD
Meropenem—Thrombophlebitis—Methotrexate—colon cancer	0.00277	0.00277	CcSEcCtD
Meropenem—Anaemia—Vincristine—colon cancer	0.00275	0.00275	CcSEcCtD
Meropenem—Agitation—Vincristine—colon cancer	0.00273	0.00273	CcSEcCtD
Meropenem—Anaemia—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Meropenem—Hepatic failure—Methotrexate—colon cancer	0.00266	0.00266	CcSEcCtD
Meropenem—Leukopenia—Vincristine—colon cancer	0.00266	0.00266	CcSEcCtD
Meropenem—Malaise—Irinotecan—colon cancer	0.00261	0.00261	CcSEcCtD
Meropenem—Neutropenia—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Meropenem—Dysuria—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Meropenem—Syncope—Irinotecan—colon cancer	0.0026	0.0026	CcSEcCtD
Meropenem—Leukopenia—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Meropenem—Hypertension—Vincristine—colon cancer	0.00257	0.00257	CcSEcCtD
Meropenem—Anaemia—Fluorouracil—colon cancer	0.00256	0.00256	CcSEcCtD
Meropenem—Loss of consciousness—Irinotecan—colon cancer	0.00254	0.00254	CcSEcCtD
Meropenem—Cough—Irinotecan—colon cancer	0.00253	0.00253	CcSEcCtD
Meropenem—Hypertension—Irinotecan—colon cancer	0.0025	0.0025	CcSEcCtD
Meropenem—Pneumonia—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Meropenem—Leukopenia—Fluorouracil—colon cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Infestation—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Infestation NOS—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Meropenem—Acute coronary syndrome—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Meropenem—Renal failure—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Meropenem—Myocardial infarction—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Neuropathy peripheral—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Oedema—Vincristine—colon cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Anaphylactic shock—Vincristine—colon cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Jaundice—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Infection—Vincristine—colon cancer	0.00241	0.00241	CcSEcCtD
Meropenem—Confusional state—Irinotecan—colon cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Nervous system disorder—Vincristine—colon cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Thrombocytopenia—Vincristine—colon cancer	0.00237	0.00237	CcSEcCtD
Meropenem—Oedema—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Meropenem—Anaphylactic shock—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Meropenem—Chest pain—Fluorouracil—colon cancer	0.00236	0.00236	CcSEcCtD
Meropenem—Infection—Irinotecan—colon cancer	0.00235	0.00235	CcSEcCtD
Meropenem—Hyperhidrosis—Vincristine—colon cancer	0.00234	0.00234	CcSEcCtD
Meropenem—Hepatobiliary disease—Capecitabine—colon cancer	0.00234	0.00234	CcSEcCtD
Meropenem—Epistaxis—Capecitabine—colon cancer	0.00234	0.00234	CcSEcCtD
Meropenem—Shock—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Meropenem—Nervous system disorder—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Meropenem—Agranulocytosis—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Meropenem—Thrombocytopenia—Irinotecan—colon cancer	0.00231	0.00231	CcSEcCtD
Meropenem—Anorexia—Vincristine—colon cancer	0.00231	0.00231	CcSEcCtD
Meropenem—Hyperhidrosis—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Confusional state—Fluorouracil—colon cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Hypotension—Vincristine—colon cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Bradycardia—Capecitabine—colon cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Anaphylactic shock—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Oedema—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Anorexia—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Meropenem—Infection—Fluorouracil—colon cancer	0.00225	0.00225	CcSEcCtD
Meropenem—Haemoglobin—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Meropenem—Haemorrhage—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Meropenem—Hepatitis—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Meropenem—Nervous system disorder—Fluorouracil—colon cancer	0.00222	0.00222	CcSEcCtD
Meropenem—Thrombocytopenia—Fluorouracil—colon cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Pharyngitis—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Tachycardia—Fluorouracil—colon cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Hypotension—Irinotecan—colon cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Insomnia—Vincristine—colon cancer	0.00219	0.00219	CcSEcCtD
Meropenem—Oedema peripheral—Capecitabine—colon cancer	0.00219	0.00219	CcSEcCtD
Meropenem—Paraesthesia—Vincristine—colon cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Anorexia—Fluorouracil—colon cancer	0.00216	0.00216	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Meropenem—Insomnia—Irinotecan—colon cancer	0.00214	0.00214	CcSEcCtD
Meropenem—Paraesthesia—Irinotecan—colon cancer	0.00212	0.00212	CcSEcCtD
Meropenem—Hypotension—Fluorouracil—colon cancer	0.00211	0.00211	CcSEcCtD
Meropenem—Decreased appetite—Vincristine—colon cancer	0.00211	0.00211	CcSEcCtD
Meropenem—Dyspnoea—Irinotecan—colon cancer	0.00211	0.00211	CcSEcCtD
Meropenem—Erythema multiforme—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Meropenem—Somnolence—Irinotecan—colon cancer	0.0021	0.0021	CcSEcCtD
Meropenem—Gastrointestinal disorder—Vincristine—colon cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Dyspepsia—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Meropenem—Pain—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Constipation—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Asthma—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Decreased appetite—Irinotecan—colon cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Eosinophilia—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Insomnia—Fluorouracil—colon cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Gastrointestinal disorder—Irinotecan—colon cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Paraesthesia—Fluorouracil—colon cancer	0.00203	0.00203	CcSEcCtD
Meropenem—Pain—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Constipation—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Dyspnoea—Fluorouracil—colon cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Somnolence—Fluorouracil—colon cancer	0.00201	0.00201	CcSEcCtD
Meropenem—Immune system disorder—Capecitabine—colon cancer	0.00201	0.00201	CcSEcCtD
Meropenem—Chills—Capecitabine—colon cancer	0.002	0.002	CcSEcCtD
Meropenem—Dyspepsia—Fluorouracil—colon cancer	0.00199	0.00199	CcSEcCtD
Meropenem—Gastrointestinal pain—Vincristine—colon cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Decreased appetite—Fluorouracil—colon cancer	0.00197	0.00197	CcSEcCtD
Meropenem—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Meropenem—Feeling abnormal—Irinotecan—colon cancer	0.00195	0.00195	CcSEcCtD
Meropenem—Erythema—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Dysuria—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Neutropenia—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Pain—Fluorouracil—colon cancer	0.00193	0.00193	CcSEcCtD
Meropenem—Gastrointestinal pain—Irinotecan—colon cancer	0.00193	0.00193	CcSEcCtD
Meropenem—Abdominal pain—Vincristine—colon cancer	0.00192	0.00192	CcSEcCtD
Meropenem—Body temperature increased—Vincristine—colon cancer	0.00192	0.00192	CcSEcCtD
Meropenem—Flatulence—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Meropenem—Dysgeusia—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Back pain—Capecitabine—colon cancer	0.00187	0.00187	CcSEcCtD
Meropenem—Abdominal pain—Irinotecan—colon cancer	0.00187	0.00187	CcSEcCtD
Meropenem—Body temperature increased—Irinotecan—colon cancer	0.00187	0.00187	CcSEcCtD
Meropenem—Feeling abnormal—Fluorouracil—colon cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Pneumonia—Methotrexate—colon cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Infestation NOS—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Infestation—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Renal failure—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Meropenem—Urticaria—Fluorouracil—colon cancer	0.0018	0.0018	CcSEcCtD
Meropenem—Anaemia—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Meropenem—Body temperature increased—Fluorouracil—colon cancer	0.00179	0.00179	CcSEcCtD
Meropenem—Hypersensitivity—Vincristine—colon cancer	0.00179	0.00179	CcSEcCtD
Meropenem—Sweating—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Meropenem—Malaise—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—colon cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Hypersensitivity—Irinotecan—colon cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Asthenia—Vincristine—colon cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Syncope—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Leukopenia—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Meropenem—Loss of consciousness—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Meropenem—Asthenia—Irinotecan—colon cancer	0.00169	0.00169	CcSEcCtD
Meropenem—Cough—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Meropenem—Hypertension—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Hypersensitivity—Fluorouracil—colon cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Diarrhoea—Vincristine—colon cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Chest pain—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—colon cancer	0.00164	0.00164	CcSEcCtD
Meropenem—Anxiety—Capecitabine—colon cancer	0.00164	0.00164	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00164	0.00164	CcSEcCtD
Meropenem—Diarrhoea—Irinotecan—colon cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Dizziness—Vincristine—colon cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Pruritus—Fluorouracil—colon cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Confusional state—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Oedema—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Meropenem—Infection—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Dizziness—Irinotecan—colon cancer	0.00156	0.00156	CcSEcCtD
Meropenem—Shock—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Meropenem—Nervous system disorder—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Meropenem—Diarrhoea—Fluorouracil—colon cancer	0.00155	0.00155	CcSEcCtD
Meropenem—Thrombocytopenia—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Meropenem—Tachycardia—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Vomiting—Vincristine—colon cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Skin disorder—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Rash—Vincristine—colon cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Hyperhidrosis—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Dermatitis—Vincristine—colon cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Headache—Vincristine—colon cancer	0.00152	0.00152	CcSEcCtD
Meropenem—Anorexia—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Meropenem—Vomiting—Irinotecan—colon cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—colon cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Dizziness—Fluorouracil—colon cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Rash—Irinotecan—colon cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Dermatitis—Irinotecan—colon cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Chills—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Headache—Irinotecan—colon cancer	0.00148	0.00148	CcSEcCtD
Meropenem—Hypotension—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Meropenem—Erythema—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Nausea—Vincristine—colon cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Vomiting—Fluorouracil—colon cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Insomnia—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Rash—Fluorouracil—colon cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Dermatitis—Fluorouracil—colon cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Paraesthesia—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Headache—Fluorouracil—colon cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—colon cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Dyspnoea—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Nausea—Irinotecan—colon cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Back pain—Methotrexate—colon cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Dyspepsia—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Decreased appetite—Capecitabine—colon cancer	0.00137	0.00137	CcSEcCtD
Meropenem—Gastrointestinal disorder—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Constipation—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Pain—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Nausea—Fluorouracil—colon cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Anaemia—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Meropenem—Feeling abnormal—Capecitabine—colon cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Malaise—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Gastrointestinal pain—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Cough—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Urticaria—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Abdominal pain—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Body temperature increased—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Chest pain—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Confusional state—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Infection—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Hypersensitivity—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Asthenia—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Anorexia—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Pruritus—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Hypotension—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Diarrhoea—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Meropenem—Insomnia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Somnolence—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Dizziness—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Pain—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Vomiting—Capecitabine—colon cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Rash—Capecitabine—colon cancer	0.000997	0.000997	CcSEcCtD
Meropenem—Dermatitis—Capecitabine—colon cancer	0.000996	0.000996	CcSEcCtD
Meropenem—Headache—Capecitabine—colon cancer	0.00099	0.00099	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—colon cancer	0.00097	0.00097	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—colon cancer	0.000962	0.000962	CcSEcCtD
Meropenem—Nausea—Capecitabine—colon cancer	0.000939	0.000939	CcSEcCtD
Meropenem—Urticaria—Methotrexate—colon cancer	0.000935	0.000935	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—colon cancer	0.00093	0.00093	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—colon cancer	0.00093	0.00093	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—colon cancer	0.000867	0.000867	CcSEcCtD
Meropenem—Asthenia—Methotrexate—colon cancer	0.000844	0.000844	CcSEcCtD
Meropenem—Pruritus—Methotrexate—colon cancer	0.000833	0.000833	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—colon cancer	0.000805	0.000805	CcSEcCtD
Meropenem—Dizziness—Methotrexate—colon cancer	0.000778	0.000778	CcSEcCtD
Meropenem—Vomiting—Methotrexate—colon cancer	0.000748	0.000748	CcSEcCtD
Meropenem—Rash—Methotrexate—colon cancer	0.000742	0.000742	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—colon cancer	0.000741	0.000741	CcSEcCtD
Meropenem—Headache—Methotrexate—colon cancer	0.000737	0.000737	CcSEcCtD
Meropenem—Nausea—Methotrexate—colon cancer	0.000699	0.000699	CcSEcCtD
